URGN · UroGen Pharma Ltd. · Documents
$35.29
+1.14 (+3.34%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$1.71B
Shares
48.88M
Volume · Oct 20
186.44K
Avg daily vol (3M)
888.41K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2026-09-15 | 2026-09-30 | |
| Investor Event Transcript | — | 2026-09-09 | 2026-09-30 | |
| 8-K | — | 2026-08-20 | 2026-08-18 | |
| 10-Q | — | 2026-08-05 | 2026-06-30 | |
| 8-K | — | 2026-08-05 | — | |
| 8-K | — | 2026-06-23 | 2026-06-22 | |
| 8-K | — | 2026-06-02 | — | |
| ARS | — | 2026-05-27 | 2025-12-31 | |
| Investor Event Transcript | — | 2026-05-19 | 2026-06-30 | |
| 10-Q | — | 2026-05-06 | 2026-03-31 | |
| 8-K | — | 2026-05-06 | — | |
| DEF 14A | — | 2026-04-30 | 2025-12-31 | |
| PRE 14A | — | 2026-04-17 | 2025-12-31 | |
| 8-K | — | 2026-03-02 | 2026-02-26 | |
| 8-K | — | 2026-03-02 | — | |
| 10-K | — | 2026-03-02 | 2025-12-31 | |
| 10-Q | — | 2025-11-06 | 2025-09-30 | |
| 8-K | — | 2025-11-06 | — | |
| S-3ASR | — | 2025-11-06 | — | |
| 8-K | — | 2025-08-27 | 2025-08-26 | |
| 10-Q | — | 2025-08-07 | 2025-06-30 | |
| 8-K | — | 2025-08-07 | — | |
| ARS | — | 2025-07-16 | 2024-12-31 | |
| DEF 14A | — | 2025-07-15 | 2025-08-11 | |
| 8-K | — | 2025-07-03 | 2025-06-30 | |
| 8-K | — | 2025-06-13 | 2025-06-12 | |
| 10-Q | — | 2025-05-12 | 2025-03-31 | |
| 8-K | — | 2025-05-12 | — | |
| 10-K/A | — | 2025-04-30 | 2024-12-31 | |
| 10-K | — | 2025-03-10 | 2024-12-31 | |
| 8-K | — | 2025-03-10 | — | |
| 8-K | — | 2025-02-20 | 2025-02-14 | |
| 8-K | — | 2025-01-14 | — | |
| 8-K | — | 2024-11-06 | — | |
| 10-Q | — | 2024-11-06 | 2024-09-30 | |
| 8-K | — | 2024-10-09 | 2024-10-07 | |
| 8-K | — | 2024-09-24 | 2024-09-23 | |
| 8-K | — | 2024-09-13 | 2024-09-12 | |
| 8-K | — | 2024-08-15 | 2024-08-14 | |
| 10-Q | — | 2024-08-13 | 2024-06-30 | |
| 8-K | — | 2024-08-13 | — | |
| 8-K | — | 2024-08-08 | 2024-08-06 | |
| ARS | — | 2024-07-09 | 2023-12-31 | |
| DEFA14A | — | 2024-07-01 | — | |
| DEF 14A | — | 2024-07-01 | 2024-08-07 | |
| 8-K | — | 2024-06-18 | 2024-06-17 | |
| 8-K | — | 2024-06-13 | — | |
| 10-Q | — | 2024-05-13 | 2024-03-31 | |
| 8-K | — | 2024-05-13 | — | |
| 10-K/A | — | 2024-04-29 | 2023-12-31 |
Showing 1–50 of 124 filings
Key facts
CIK
1668243
CUSIP
M96088105
13F (30d)
11 filings
11 filers
Visit website
Investor relations